NCT02305316View on ClinicalTrials.gov

Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Parkinson Disease
Interventions
DRUG

BIA 9-1067 non-micronized

DRUG

BIA 9-1067 micronized

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02305316 - Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone | Biotech Hunter | Biotech Hunter